Regulatory pauses, pricing lawsuits and pharma investment moves shape today’s headlines

February 3, 2026

1. The leverage Duke Health is using to grow pharmacy Full story

2. TrumpRx launch delayed Full story

3. Using genetic data to guide medication choices can improve efficacy and reduce adverse effects. See why pharmacogenomics matters. Learn more.

 

4. FDA puts hold on gene therapy trials after brain tumor reported Full story

5. Penn State sues insulin makers, PBMs over pricing scheme Full story

6. 1 switch, 130+ hours saved: see this California hospital's winning pharmacy strategy here.

 

7. FDA delays approval for anaphylaxis drug Full story

8. Eli Lilly plans $3.5B injectable manufacturing site in Pennsylvania Full story

9. Growth under pressure: How CEOs are moving forward in 2026 Full story

10. Shutdown enters 4th day: 3 updates Full story

11. The 10 fastest-growing states in the US Full story

 

12. Cardiology's shifting fast. How Advocate, Baptist Health South Florida + Fairview are adapting systemwide here.

Becker's Learning Opportunities

13. Ambulatory leaders demand proof of 5–10% ROI for RCM tech investment. See the data here.

14. Half of patients skip care due to cost. 3 steps for restoring access here.

15. Hospital occupancy is already 75%. The model to create capacity without adding beds here.

16. Interested in more? See Becker’s full lineup of webinars and whitepapers.

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 

 

Contact Us, Feedback, or Questions – Email ptwenter@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication